financetom
Business
financetom
/
Business
/
GSR III Acquisition, Terra Innovatum Secure $37.5 Million Equity Financing for Business Combination
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GSR III Acquisition, Terra Innovatum Secure $37.5 Million Equity Financing for Business Combination
Sep 25, 2025 6:32 AM

09:12 AM EDT, 09/25/2025 (MT Newswires) -- GSR III Acquisition ( GSRT ) , and micro-modular nuclear reactor developer Terra Innovatum said Thursday they have secured $37.5 million in committed financing for their pending business combination.

The financing includes about $32 million of private investment in public equity capital led by Segra Capital Management and about $5.5 million from a funded bridge facility, which will convert to common equity at the business combination's close, the companies said.

Proceeds from the financing will be used to help support licensing and construction of Terra Innovatum's "Solo" micro-modular reactor, the companies said.

They said they expect their business combination to close shortly after the Oct. 7 extraordinary general meeting of GSR III Acquisition ( GSRT ) shareholders if the proposals are approved.

The post-combination company will be named Terra Innovatum, whose common shares are expected to trade on Nasdaq under the ticker symbol "NKLR," the companies said.

Shares of GSR III Acquisition ( GSRT ) were down nearly 2% in recent Thursday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
F.N.B. Q3 Adjusted Earnings, Revenue Increase
F.N.B. Q3 Adjusted Earnings, Revenue Increase
Oct 16, 2025
05:12 PM EDT, 10/16/2025 (MT Newswires) -- F.N.B. (FNB) reported Q3 adjusted earnings Thursday of $0.41 per diluted share, up from $0.34 a year earlier. Analysts polled by FactSet expected $0.37. Revenue for the quarter, expressed as the sum of net interest income and total noninterest income, was $457.4 million, up from $413 million a year earlier. Analysts surveyed by...
Emergent Biosolutions Insider Sold Shares Worth $306,080, According to a Recent SEC Filing
Emergent Biosolutions Insider Sold Shares Worth $306,080, According to a Recent SEC Filing
Oct 16, 2025
04:28 PM EDT, 10/16/2025 (MT Newswires) -- Coleen Glessner, Executive Vice President, Quality, Ethics, and Compliance, on October 07, 2025, sold 30,608 shares in Emergent Biosolutions ( EBS ) for $306,080. Following the Form 4 filing with the SEC, Glessner has control over a total of 144,319 common shares of the company, with 144,319 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1367644/000191917025000004/xslF345X05/wk-form4_1760646078.xml...
Praxis Precision Medicines Plans Public Offering
Praxis Precision Medicines Plans Public Offering
Oct 16, 2025
04:27 PM EDT, 10/16/2025 (MT Newswires) -- Praxis Precision Medicines ( PRAX ) said late Thursday it plans a public offering of shares and prefunded warrants. The company also said it plans to grant its underwriters, including TD Cowen and Piper Sandler, a 30-day option to buy more shares. Praxis shares were up over 4% during after-hours activity. ...
CoreWeave Reaffirms Strategic Rationale of its Proposed Acquisition and Financial Benefits to Core Scientific Stockholders
CoreWeave Reaffirms Strategic Rationale of its Proposed Acquisition and Financial Benefits to Core Scientific Stockholders
Oct 16, 2025
Urges Core Scientific Stockholders to Vote FOR the Proposed Transaction LIVINGSTON, N.J.--(BUSINESS WIRE)-- CoreWeave Inc. ( CRWV ) , The Essential Cloud for AI, today released the following open letter to stockholders of Core Scientific, Inc. ( CORZ ) . The letter reaffirms CoreWeave’s commitment to the proposed acquisition of Core Scientific ( CORZ ) on the previously agreed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved